MCID: DBT004
MIFTS: 52

Diabetic Polyneuropathy malady

Neuronal category

Summaries for Diabetic Polyneuropathy

Sources:
33MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Diabetic Polyneuropathy, also known as diabetes mellitus with polyneuropathy, is related to diabetic autonomic neuropathy and autonomic neuropathy. An important gene associated with Diabetic Polyneuropathy is AKR1B1 (aldo-keto reductase family 1, member B1 (aldose reductase)), and among its related pathways are Oxidative Stress Regulatory Pathway (Erythrocyte) and Platinum Pathway, Pharmacokinetics/Pharmacodynamics. The compounds tetrahydrobiopterin and cycloheximide have been mentioned in the context of this disorder. Affiliated tissues include skin, spinal cord and brain, and related mouse phenotypes are adipose tissue and renal/urinary system.

Aliases & Classifications for Diabetic Polyneuropathy

Sources:
8Disease Ontology, 45Novoseek, 61UMLS, 57SNOMED-CT, 27ICD9CM, 35MeSH, 25ICD10
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Anatomical: Neuronal


Aliases & Descriptions:

diabetic polyneuropathy 8 45
diabetes mellitus with polyneuropathy 8
polyneuropathy in diabetes 8
diabetic polyneuropathies 61


External Ids:

Disease Ontology8 DOID:12785
ICD9CM27 357.2
MeSH35 D003929
ICD1025 G63.2

Related Diseases for Diabetic Polyneuropathy

Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Diabetic Polyneuropathy via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 190)
idRelated DiseaseScoreTop Affiliating Genes
1diabetic autonomic neuropathy30.3NGF, AKR1B1
2autonomic neuropathy30.3NGF, NTF3, AKR1B1
3carpal tunnel syndrome10.4
4n syndrome10.2
5chronic inflammatory demyelinating polyneuropathy10.2
6diabetes, type 210.2
7autonomic peripheral neuropathy10.0
8pain disorder10.0
9brain disease10.0
10vestibular disease10.0
11micro syndrome10.0
12phosphoglycerate mutase deficiency10.0
13autonomic dysfunction10.0
14chronic pain10.0
15postherpetic neuralgia10.0
16neuroblastoma10.0NGF
17peritonitis10.0LIF
18cystitis10.0NGF
19eclampsia10.0THBD
20dilated cardiomyopathy10.0SLC25A4
21cerebrovascular disease10.0SOD3
22pancreatitis10.0SOD2
23lupus erythematosus10.0THBD
24nephritis10.0LIF
25ophthalmoplegia10.0SLC25A4
26atopic dermatitis10.0NGF
27vasculitis10.0THBD
28hypogonadism10.0POLG
29choriocarcinoma10.0LIF
30meningioma10.0GSTT1
31pituitary tumors10.0LIF
32liver cirrhosis10.0NOS3
33migraine10.0GSTM1
34vitiligo10.0CAT
35lupus nephritis10.0THBD
36cystic fibrosis10.0GSTM1
37meningitis10.0CAT
38spermatic cord torsion10.0CAT
39skin cancer10.0CAT
40pneumoconiosis10.0CAT
41graves' disease10.0NOS3
42sickle cell disease10.0NOS3
43glaucoma10.0CNTF, AKR1B1
44primary open angle glaucoma10.0GSTM1
45hepatopulmonary syndrome10.0NOS3
46blindness10.0CNTF, AKR1B1
47schistosomiasis10.0GSTM1
48mitochondrial disorders10.0POLG
49hypoglycemia10.0POLG, AKR1B1
50dermatitis10.0LIF, NTF3

Graphical network of the top 20 diseases related to Diabetic Polyneuropathy:



Diseases related to diabetic polyneuropathy

Clinical Features for Diabetic Polyneuropathy

Drugs & Therapeutics for Diabetic Polyneuropathy

Sources:
5CenterWatch, 42NIH Clinical Center, 6ClinicalTrials, 61UMLS, 41NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Diabetic Polyneuropathy

Drug clinical trials:

Search ClinicalTrials for Diabetic Polyneuropathy

Search NIH Clinical Center for Diabetic Polyneuropathy

Search CenterWatch for Diabetic Polyneuropathy

Genetic Tests for Diabetic Polyneuropathy

Anatomical Context for Diabetic Polyneuropathy

Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Diabetic Polyneuropathy:

33
Skin, Spinal cord, Brain, Kidney, Bone marrow, Pancreas, T cells, B cells, Endothelial, Thalamus

Animal Models for Diabetic Polyneuropathy or affiliated genes

Sources:
37MGI, 28inGenious Targeting Laboratory
See all sources

MGI Mouse Phenotypes related to Diabetic Polyneuropathy:

37 (show all 19)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000537510.2POLG, LIF
2MP:00053679.9SOD2, AKR1B1, NOS1
3MP:00053909.3LIF, POLG, NOS3, SOD3, NOS1, AKR1B1
4MP:00053919.3NOS1, GPX1, NGF, NTF3, LIF, AKR1B1
5MP:00053699.2NOS3, NOS1, NGF, NTF3, POLG, CNTF
6MP:00107719.2LIF, SOD2, POLG, PARP1
7MP:00053959.2SOD2, NOS3, NOS2, NOS1
8MP:00053899.1SOD2, BMP6, NTF3, POLG, PARP1, LIF
9MP:00036318.9NOS2, GPX1, CNTF, POLG, LIF, NOS1
10MP:00053708.8NOS1, NOS2, NOS3, THBD, LIF, SOD2
11MP:00053818.7NOS1, LIF, GPX1, THBD, NOS3, POLG
12MP:00053768.6NGF, GPX1, SOD3, AKR1B1, LIF, NTF3
13MP:00053868.3NGF, LIF, NTF3, AKR1B1, SOD2, NOS3
14MP:00053978.3SOD2, CNTF, GPX1, THBD, POLG, NOS3
15MP:00053858.2C10orf2, SOD2, LIF, NTF3, POLG, NGF
16MP:00053877.9PARP1, SOD3, SOD2, LIF, POLG, THBD
17MP:00053787.5NTF3, POLG, NGF, GPX1, THBD, NOS3
18MP:00107687.2AKR1B1, NOS2, NOS3, C10orf2, THBD, GPX1
19MP:00053847.2NOS3, SOD2, GSTM1, NOS2, SLC25A4, THBD

Publications for Diabetic Polyneuropathy

Sources:
51PubMed
See all sources

Articles related to Diabetic Polyneuropathy:

(show top 50)    (show all 298)
idTitleAuthorsYear
1
Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice. (24319678)
2013
2
Vascular factors predict polyneuropathy in a non-diabetic elderly population. (22893359)
2013
3
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. (23970715)
2013
4
Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects. (22734904)
2012
5
Thermal threshold: research study on small fiber dysfunction in distal diabetic polyneuropathy. (22401337)
2012
6
Evaluation of diabetic polyneuropathy in Type 2 diabetes mellitus by nerve conduction study and association of severity of neuropathy with serum sFasL level. (23565468)
2012
7
Understanding diabetic polyneuropathy and longevity: what can we learn from the nematode Caenorhabditis elegans? (22402951)
2012
8
Chronic inflammatory demyelinating polyneuropathy mimicking diabetic neuropathy in a young female with type 2 diabetes mellitus. (22293929)
2012
9
Multifocal Visual Evoked Potentials (mfVEP) in Diabetic Patients with and without Polyneuropathy. (23198007)
2012
10
Useful application of the neuropad test for assessment of diabetic polyneuropathy. (23207118)
2012
11
Letter: diabetic polyneuropathy and cardiovascular complications in type 2 diabetic patients (diabetes metab j 2011;35:390-6). (22111049)
2011
12
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. (21941444)
2011
13
Small Fiber Neuropathy: Role in the diagnosis of Diabetic Sensorimotor Polyneuropathy. (21695760)
2011
14
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. (21434993)
2011
15
Importance of pain evaluation for more accurate diagnosis of painful diabetic polyneuropathy. (21467831)
2010
16
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. (19399887)
2009
17
Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). (19131463)
2009
18
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. (19301937)
2009
19
Comparison of nerve conduction studies with diabetic neuropathy symptom score and diabetic neuropathy examination score in type-2 diabetics for detection of sensorimotor polyneuropathy. (19750851)
2009
20
Association of the T(-365)C POLG1, G(-25)A ANT1 and G(-605)T PEO1 gene polymorphisms with diabetic polyneuropathy in patients with type 1 diabetes mellitus]. (19425506)
2009
21
Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy. (18825430)
2008
22
Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. (17875242)
2007
23
Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy. (18250616)
2007
24
Comparison of the utility of sympathetic skin response and current perception threshold examinations with conventional examinations for the early electrophysiological diagnosis of diabetic polyneuropathy. (17191732)
2006
25
Visual evoked potentials and diabetic polyneuropathy. (17122936)
2006
26
Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy. (15855584)
2005
27
Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based. (15529620)
2004
28
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. (14984445)
2004
29
Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. (15355485)
2004
30
Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. (16026113)
2004
31
Distal site testing of sympathetic skin response (big toe) in diabetic polyneuropathy. (15666069)
2004
32
Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. (14668051)
2003
33
Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy. (11870689)
2002
34
The role of glycation in the pathogenesis of diabetic polyneuropathy. (11724915)
2001
35
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat. (11508275)
2001
36
F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. (10952465)
2000
37
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. (11056593)
2000
38
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. (10480512)
1999
39
Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. (9583761)
1998
40
Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy. Italian General Practitioner Study Group (IGPSG). (9325473)
1997
41
Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. (8902721)
1996
42
Comparison of clinical examination, current and vibratory perception threshold in diabetic polyneuropathy. (8208323)
1994
43
Efficiency of the antihypoxic substance sabeluzole in patients with clinically and neurophysiologically evident diabetic polyneuropathy. (8296540)
1993
44
Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. (1395463)
1992
45
Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. (1549585)
1992
46
Freeze-fracture observations on normal and abnormal human perineurial tight junctions: alterations in diabetic polyneuropathy. (2058364)
1991
47
Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. (2373262)
1990
48
Variability of three standard neurophysiological techniques in established symptomatic diabetic polyneuropathy. (2635095)
1989
49
Diabetic polyneuropathy and insulin secretion in type II diabetic patients. (3315688)
1987
50
Analysis of conduction velocity in the H pathway. Part 2. An electrophysiological study in diabetic polyneuropathy. (7276975)
1981

Genetic Variations for Diabetic Polyneuropathy

Expression for genes affiliated with Diabetic Polyneuropathy

Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Diabetic Polyneuropathy

Search GEO for disease gene expression data for Diabetic Polyneuropathy.

Pathways for genes affiliated with Diabetic Polyneuropathy

Sources:
50PharmGKB, 38NCBI BioSystems Database, 52QIAGEN, 30KEGG, 12EMD Millipore, 54Reactome
See all sources

Pathways related to Diabetic Polyneuropathy according to GeneCards/GeneDecks:

(show all 22)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.0CAT, GPX1
210.0GSTT1, GSTM1
310.0GSTT1, GSTM1
49.8CAT, SOD3, GPX1
5
Hide members
9.8CNTF, LIF, SOD2
6
Naphthalene metabolism
Hide members
9.8AKR1B1, GSTM1, GSTT1
79.8SOD2, SOD3, CAT
8
Glutathione metabolism
Hide members
9.8GPX1, GSTM1, GSTT1
99.8NOS3, THBD, LIF
10
Hide members
9.7NOS1, GPX1, CAT
119.6CAT, SOD3, SOD2, GPX1
129.6CAT, SOD3, SOD2, GPX1
139.6NOS2, SOD2, CAT
149.5NOS3, NOS2, NOS1
15
NO-dependent CFTR activation (normal and CF)
9.5NOS3, NOS2, NOS1
169.5NOS3, NOS2, NOS1
17
Hide members
9.5NOS1, NOS2, NOS3
18
CFTR folding and maturation (norm and CF)
9.5NOS1, NOS2, NOS3
19
Hide members
9.3NOS2, NOS3, GPX1, CAT
209.3SLC25A4, NOS3, NOS2, NOS1
21
Hide members
9.3THBD, NOS3, NOS2, NOS1
22
Hide members
8.6GPX1, SLC25A4, NOS3, NOS2, NOS1, GSTM1

Compounds for genes affiliated with Diabetic Polyneuropathy

Sources:
45Novoseek, 11DrugBank, 24HMDB, 60Tocris Bioscience, 29IUPHAR, 50PharmGKB, 2BitterDB
See all sources

Compounds related to Diabetic Polyneuropathy according to GeneCards/GeneDecks:

(show top 50)    (show all 243)
idCompoundScoreTop Affiliating Genes
1tetrahydrobiopterin45 11 2412.1NOS3, NOS1, AKR1B1
2cycloheximide4510.0PARP1, SOD2, CAT
3nadph45 2411.0SOD3, SOD2, GPX1, NOS1
4indomethacin45 60 29 1112.9NOS1, NOS3, NGF, AKR1B1
5alpha tocopherol459.8GPX1, GSTM1, LIF, SOD2
6norepinephrine45 11 2411.8NTF3, BMP6, LIF, CNTF
78-oxo-dg459.6SOD2, GSTT1, CAT, GSTM1, GPX1
8gamma-glutamylcysteine45 11 2411.6GPX1, GSTM1, CAT, SOD3, SOD2
9superoxide45 2410.5SOD3, NOS1, NOS3, CNTF, NTF3, LIF
10ptio459.5NOS2, NOS3, NOS1, CAT
11onoo459.5SOD2, NOS3, NOS1, NOS2
12aminoguanidine45 29 1111.5SOD2, AKR1B1, NOS3, NOS2, NOS1
13cyclosporin a45 29 6011.5NOS1, AKR1B1, THBD, NGF, LIF, SLC25A4
14pdtc459.4CAT, NGF, NOS2, NOS1, SOD2
15vitamin-e459.4GSTT1, NTF3, CAT, CNTF, THBD, GPX1
16manganese superoxide459.4GSTM1, GPX1, SOD2, CAT, SOD3, GSTT1
17malondialdehyde459.4GSTT1, GSTM1, GPX1, SOD2, SOD3, CAT
18h2o2459.3CAT, AKR1B1, LIF, CNTF, PARP1, THBD
19selenium45 2410.3LIF, GPX1, SOD2, CAT, SOD3
20choline45 11 2411.1NOS1, NOS3, NGF, NTF3, LIF, CNTF
21silymarin459.1NOS2, CAT, BMP6, AKR1B1, PARP1
22s-nitroso-n-acetylpenicillamine459.1NOS3, NOS1, NOS2, AKR1B1, CAT, PARP1
23folate459.1GSTT1, GSTM1, NOS1, NOS3, SOD2, SOD3
24vitamin d459.1GSTM1, THBD, NGF, BMP6, SOD2, SOD3
25carbachol45 29 1111.0NOS1, NTF3, NGF, LIF, BMP6, NOS3
264-hydroxynonenal45 2410.0PARP1, NOS2, GPX1, CAT, GSTM1, SOD2
27dopamine45 29 11 2412.0NOS1, BMP6, GSTM1, SOD2, CNTF, LIF
28betacarotene458.9SOD2, LIF, THBD, CAT, GSTM1
29oxygen45 249.9NOS1, NOS2, SOD3, AKR1B1, POLG, SLC25A4
30creatinine458.9NGF, BMP6, GSTT1, GSTM1, AKR1B1, SLC25A4
31n acetylcysteine458.9PARP1, NOS2, CNTF, CAT, SOD3, GPX1
32adenylate458.9SLC25A4, SOD3, AKR1B1, NTF3, POLG, CNTF
33curcumin458.8CAT, SOD2, AKR1B1, NOS2, PARP1, THBD
34sodium nitroprusside458.8NOS3, NOS1, CAT, SOD2, BMP6, NOS2
35peroxynitrite458.7NOS1, CAT, SOD3, SOD2, GPX1, NOS3
36lactate458.7BMP6, AKR1B1, LIF, SOD2, CAT, THBD
37ly294002458.6SOD2, BMP6, CNTF, NGF, NOS2, PARP1
38cisplatin45 50 60 1111.6LIF, GSTT1, GSTM1, PARP1, SOD2, BMP6
39alanine458.5NGF, GPX1, THBD, SOD2, CNTF, POLG
40sb 20358045 609.4CAT, BMP6, LIF, NGF, NOS3, NOS2
41genistein45 29 60 2 11 2413.4NTF3, LIF, AKR1B1, NOS2, NOS1, NOS3
42acetylcholine45 50 29 11 2412.3SOD3, BMP6, NTF3, NGF, LIF, SOD2
43actinomycin d458.2NGF, LIF, AKR1B1, SOD2, NTF3, CNTF
44retinoic acid45 249.2NGF, NOS1, NOS3, SLC25A4, THBD, CNTF
45cysteine458.1NTF3, SOD3, PARP1, NOS1, THBD, GPX1
46ascorbic acid45 248.9GSTM1, NOS1, NOS2, NOS3, THBD, CNTF
47arginine457.9NTF3, NGF, GSTM1, THBD, NOS3, NOS1
48nitric oxide45 11 249.8SOD3, GPX1, THBD, NOS1, NOS2, NOS3
49doxorubicin45 50 119.8GPX1, PARP1, GSTM1, NOS1, NOS2, NOS3
50vegf457.6NOS3, THBD, NGF, CNTF, NTF3, LIF

GO Terms for genes affiliated with Diabetic Polyneuropathy

Sources:
16Gene Ontology
See all sources

Cellular components related to Diabetic Polyneuropathy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial nucleoidGO:0426459.7POLG, SOD2, C10orf2
2extracellular spaceGO:0056159.1SOD3, BMP6, AKR1B1, LIF, CNTF, NGF
3cytosolGO:0058297.9NOS1, NOS2, NOS3, GPX1, AKR1B1, SOD3

Biological processes related to Diabetic Polyneuropathy according to GeneCards/GeneDecks:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1mitochondrial DNA replicationGO:00626410.3POLG, C10orf2
2muscle organ morphogenesisGO:04864410.3LIF, CNTF
3response to selenium ionGO:01026910.2GPX1, SOD2
4negative regulation of platelet activationGO:01054410.1THBD, NOS3
5negative regulation of hydrolase activityGO:05134610.1NOS1, NOS3
6negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:190204210.1NOS3, GPX1
7neuron developmentGO:04866610.1CNTF, LIF, SOD2
8removal of superoxide radicalsGO:01943010.1SOD3, SOD2
9peptidyl-cysteine S-nitrosylationGO:01811910.1NOS1, NOS2
10negative regulation of neuron apoptotic processGO:04352410.0SOD2, NTF3, CNTF, NGF
11negative regulation of potassium ion transportGO:0432679.9NOS3, NOS1
12response to hyperoxiaGO:0550939.9SOD2, CAT
13UV protectionGO:0096509.9CAT, GPX1
14glutathione metabolic processGO:0067499.9GSTT1, GSTM1, GPX1, SOD2
15positive regulation of guanylate cyclase activityGO:0312849.9NOS1, NOS2, NOS3
16arginine catabolic processGO:0065279.9NOS3, NOS2, NOS1
17nitric oxide biosynthetic processGO:0068099.8NOS3, NOS2, NOS1
18nitric oxide mediated signal transductionGO:0072639.8NOS1, NOS2, NOS3
19positive regulation of vasodilationGO:0459099.8NOS3, NOS2, NOS1
20negative regulation of blood pressureGO:0457769.8NOS3, NOS2, NOS1
21interaction with hostGO:0517019.8NOS3, NOS2, NOS1
22phagosome maturationGO:0903829.8NOS1, NOS2, NOS3
23purine nucleotide catabolic processGO:0061959.7CAT, GPX1
24response to hypoxiaGO:0016669.4NOS1, NOS2, SOD2, SOD3, CAT
25small molecule metabolic processGO:0442819.0CAT, AKR1B1, GPX1, SLC25A4, NOS3, GSTM1

Molecular functions related to Diabetic Polyneuropathy according to GeneCards/GeneDecks:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1superoxide dismutase activityGO:00478410.1SOD3, SOD2
2nitric-oxide synthase activityGO:0045179.8NOS1, NOS2, NOS3
3arginine bindingGO:0346189.7NOS3, NOS2, NOS1
4tetrahydrobiopterin bindingGO:0346179.7NOS3, NOS2, NOS1
5NADPH-hemoprotein reductase activityGO:0039589.7NOS1, NOS2, NOS3
6FMN bindingGO:0101819.6NOS1, NOS2, NOS3
7cadmium ion bindingGO:0468709.6NOS3, NOS1
8growth factor activityGO:0080839.5BMP6, LIF, NTF3, CNTF, NGF
9receptor bindingGO:0051029.4NOS2, NTF3, LIF, CAT
10NADP bindingGO:0506619.4CAT, NOS3, NOS2, NOS1
11flavin adenine dinucleotide bindingGO:0506609.4NOS1, NOS2, NOS3
12heme bindingGO:0200379.3CAT, NOS3, NOS2, NOS1

Products for genes affiliated with Diabetic Polyneuropathy

  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Diabetic Polyneuropathy

3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet